Adis JournalsBrowse
Infographic.pdf (1.37 MB)
Download file

Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results

Download (1.37 MB)
media
posted on 2021-12-08, 16:08 authored by Adis journals on behalf of, Cristian Guja, Francesco Giorgino, Lawrence Blonde, Amar Ali, Martin Prázný, Juris J. Meier, Elisabeth Souhami, Robert Lubwama, Chen Ji, Julio Rosenstock

The above infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.

History

References

Usage metrics

Read the peer-reviewed publication

Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results
Diabetes TherapyDiabetes Therapy

Categories

Keywords

Basal insulinGLP-1 analogueGlycaemic controlHypoglycaemiaiGlarLixiSGLT2 inhibitorType 2 diabetesInfographic

Licence

CC BY-NC 4.0

Exports